144 related articles for article (PubMed ID: 9075607)
1. Effect of mazindol on body weight and insulin sensitivity in severely obese patients after a very-low-calorie diet therapy.
Nishikawa T; Iizuka T; Omura M; Kuramoto N; Miki T; Ito H; Chiba S
Endocr J; 1996 Dec; 43(6):671-7. PubMed ID: 9075607
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies with mazindol.
Inoue S
Obes Res; 1995 Nov; 3 Suppl 4():549S-552S. PubMed ID: 8697057
[TBL] [Abstract][Full Text] [Related]
3. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
Sabuncu T; Ucar E; Birden F; Yasar O
Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
[TBL] [Abstract][Full Text] [Related]
4. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
[TBL] [Abstract][Full Text] [Related]
5. Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes.
Malandrucco I; Pasqualetti P; Giordani I; Manfellotto D; De Marco F; Alegiani F; Sidoti AM; Picconi F; Di Flaviani A; Frajese G; Bonadonna RC; Frontoni S
Am J Clin Nutr; 2012 Mar; 95(3):609-13. PubMed ID: 22318758
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
7. Improved glucose metabolism after gastric bypass: evolution of the paradigm.
Pournaras DJ; Nygren J; Hagström-Toft E; Arner P; le Roux CW; Thorell A
Surg Obes Relat Dis; 2016; 12(8):1457-1465. PubMed ID: 27387696
[TBL] [Abstract][Full Text] [Related]
8. Very-low-calorie-diet therapy in severe obesity.
Yamamoto R; Inoue S; Saito M; Okamoto M; Okamura A; Takamura Y
Am J Clin Nutr; 1992 Jul; 56(1 Suppl):299S-302S. PubMed ID: 1615911
[TBL] [Abstract][Full Text] [Related]
9. Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects.
Gniuli D; Castagneto-Gissey G; Iaconelli A; Leccesi L; Mingrone G
Int J Obes (Lond); 2010 Dec; 34(12):1726-32. PubMed ID: 20498658
[TBL] [Abstract][Full Text] [Related]
10. Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient.
Capstick F; Brooks BA; Burns CM; Zilkens RR; Steinbeck KS; Yue DK
Diabetes Res Clin Pract; 1997 May; 36(2):105-11. PubMed ID: 9229194
[TBL] [Abstract][Full Text] [Related]
11. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity.
Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S; Ozawa N; Suzuki Y; Maeno H; Kato K
Diabetes Care; 1995 Jun; 18(6):775-8. PubMed ID: 7555502
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year.
Dhindsa P; Scott AR; Donnelly R
Diabet Med; 2003 Apr; 20(4):319-24. PubMed ID: 12675647
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects.
Lara-Castro C; Newcomer BR; Rowell J; Wallace P; Shaughnessy SM; Munoz AJ; Shiflett AM; Rigsby DY; Lawrence JC; Bohning DE; Buchthal S; Garvey WT
Metabolism; 2008 Jan; 57(1):1-8. PubMed ID: 18078853
[TBL] [Abstract][Full Text] [Related]
14. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
15. Changes in glucose and lipid metabolism following weight loss produced by a very low calorie diet in obese subjects.
Bryson JM; King SE; Burns CM; Baur LA; Swaraj S; Caterson ID
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):338-45. PubMed ID: 8680461
[TBL] [Abstract][Full Text] [Related]
16. Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients.
Snel M; Gastaldelli A; Ouwens DM; Hesselink MK; Schaart G; Buzzigoli E; Frölich M; Romijn JA; Pijl H; Meinders AE; Jazet IM
J Clin Endocrinol Metab; 2012 Jul; 97(7):2512-20. PubMed ID: 22569236
[TBL] [Abstract][Full Text] [Related]
17. The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women.
Svendsen PF; Jensen FK; Holst JJ; Haugaard SB; Nilas L; Madsbad S
Scand J Clin Lab Invest; 2012 Sep; 72(5):410-9. PubMed ID: 22708619
[TBL] [Abstract][Full Text] [Related]
18. Anti-obesity and anti-diabetic effects of mazindol in yellow KK mice: its activating effect on brown adipose tissue thermogenesis.
Yoshida T; Umekawa T; Wakabayashi Y; Yoshimoto K; Sakane N; Kondo M
Clin Exp Pharmacol Physiol; 1996; 23(6-7):476-82. PubMed ID: 8800569
[TBL] [Abstract][Full Text] [Related]
19. The effect of mazindol on metabolic and regulatory changes in obese women during weight reduction.
Rath R; Vondra K; Bass A; Kujalova V; Wenkeova J
Int J Obes; 1979; 3(2):133-40. PubMed ID: 93588
[TBL] [Abstract][Full Text] [Related]
20. [Effects of preoperative weight loss with a very low calorie diet (VLCD) on weight loss after biliopancreatic diversion in patients with severe obesity].
Ballesteros Pomar MD; Diez Rodríguez R; Calleja Fernández A; Vidal Casariego A; González de Francisco T; González Herráez L; Fernández VS; Calleja Antolín S; Olcoz Goñi JL; Cano Rodríguez I
Nutr Hosp; 2013; 28(1):71-7. PubMed ID: 23808432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
